Besso, M. J., Rosso, M., Lapyckyj, L., Moiola, C. P., Matos, M. L., Mercogliano, M. F., . . . Vazquez, M. H. (2019). FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways. Web
Citación estilo ChicagoBesso, María José, et al. FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways. 2019.
Cita MLABesso, María José, et al. FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways. 2019.
Precaución: Estas citas no son 100% exactas.